Meridian Clinical Trials - Presentation

5th Meridian Clinical Trials is a nexus of the clinical trials industry for networking, knowledge sharing, collaboration, and partner outreach. MCT partners with leading research institutions, private pharma-biotechs, and contract research organizations to stay updated about the latest scientific knowledge, research, and technology.

In the previous additions, MCT helped companies improve their study design and overall strategy for outsourcing, clinical operations, and development. We help companies to acquire funding and sufficient knowledge to accelerate their pipelines. It serves as an annual platform for commercial and academic organizations to discuss the business landscape in a scientific environment. Amid the COVID-19, we are promoting technologies that help conduct clinical studies remotely while reducing the overall cost of the study.

For the 5th  Meridian Clinical Trials, we have centralized our scientific approach to Artificial Intelligence, patient centricity, AI-driven study design, advanced patient recruitment & retention, early-stage development, clinical outsourcing, clinical operations and development, remote clinical trials, and more.

.

Ammar Raza
Dr. AMMAR RAZA
Regional Medical Director
Physician specialized in Clinical Diabetology/Endocrinology and Management (alumnus of Indian Institute of Management Bangalore (IIMB)) with over 2 decades in Healthcare– Pharma majors (ABBVIE, ALLERGAN, ASTRAZENECA, NOVARTIS, NOVO NORDISK, DR. REDDY’S & STRIDES ARCOLAB), & Clinical practice settings (Hospital- and office-based clinical diabetology practice).
Fatih M. Uckun M.D
Fatih M. Uckun, M.D., Ph.D
EVP, Global Head of Clinical and Medical Affairs; CSO
Fatih M. Uckun, M.D., Ph.D., is an Active Member of the American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations, including ASCO and AACR.
Prasun Mishra
Prasun Mishra, Ph.D.
Founder and CEO
Dr. Mishra (formerly with Genentech, Roche, NCI, NIH, DHHS, US Government) is the founding president and CEO of American Association for Precision Medicine (AAPM) and chair of ACT
Meridian Clinical Trials Paul-TanPiengco
Narayan Lebaka
Senior Director of Clinical Data Management
Highly motivated, astute, and results-driven self-starter with exceptional organizational, analytical, and clinical data management skills. B.S. and ten 15 + years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS).
David Jackson, M.D., MBA
David Jackson, M.D., MBA
Senior Medical Director, Neurology
David joined Triplet Therapeutics, Inc. as Senior Medical Director, Neurology in April 2021. Dr. Jackson will perform a key role in providing medical expertise and direction in global clinical drug development strategy and planning with a focus on neurodegenerative repeat expansion disorders.
Meridian Clinical Trials - Kimberly-Guede
Chris Min
VP, Head of Medical and Clinical Development
Chris is a board-certified neurologist and physician-scientist focused on the development of novel treatments for neurodegenerative diseases
Meridian Clinical Trials Paul-TanPiengco
Oscar Segurado
Chief Medical Officer
Oscar is Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).
Meridian Clinical Trials Paul-TanPiengco
Alice Drumheller
Vice President Clinical Operations
Sensei Biotherapeutics is an innovator in the field of next-generation cancer immunotherapies.
Vuong Trieu
Vuong Trieu
Chairman & CEO
Dr. Trieu, an expert in pharmaceutical development, currently serves as CEO/Chairman of Oncotelic Inc.. Previously he was President and CEO of Igdrasol- developer of 2nd generation Abraxane
Meridian Clinical Trials Paul-TanPiengco
Venkateswarlu (Venkat) Nelabhotla
President & CEO & Board Member
Venkat brings with a very rich and global experience of more than 25 years, successfully leading organizations in the biotech and cosmeceutics businesses.
Nikolaos Tezapsidis, PhD
President & CEO
Dr. Tezapsidis founded Neurotez in 2004. He is President and Chief Executive Officer and Chairman of the Board of Directors and has held these positions since the company was incorporated in 2005.
Meridian Clinical Trials - Mct
Gurdyal Kalsi, M.D.
Chief Medical Officer
Dr. Kalsi brings more than 20 years of experience in global clinical development, medical affairs, investment strategy, and regulatory affairs to Asklepion Pharmaceuticals, LLC.

Partnerships in the Pandemic: Deploying E-consent for Remote and Hybrid studies

Strategies for Patient-Centric Trial Planning and Digital Patient Engagement

Remote Monitoring and Risk Based approaches: impact on budgets and resources.

USA clinical trials regulation: An update of the correct status and some thoughts on its implementation.

Coping with ongoing challenges in conduct of clinical operations, increasing acceleration.

AI in conducting clinical trials, cheaper, faster, and more effective approach.

Designing a feasibility intelligence platform to merge advanced analytics, data science modeling, and clinical insights.

Real world evidence; the evolving landscape of regulations, data, and integrated use.

Collaborative Clinical ecosystem; how to Effectively manage partnership with patients, sites, CROs, sponsors, and regulators.

Boosting Patient Engagement in your study by building an online Patient Community.

AI powered Modelling and Design Optimization with Integrated Data and Patient Insights.

Improving retention with Patient-Centric Trial Design modeling and execution for successful trials during a pandemic.

Advance data management: data to improve strategy, execution, and outcome.

Digital Ops: Integrating and validating multiple digital devices in clinical trials.

Creating an effective vendor audit process with a risk based approach to ensure success in remote trials.

Creating, maintaining, regulating, and growing an online Patient community.

Developing an effective clinical outsourcing strategy; analyzing risks and benefits.

Clinical Trials in the era of digitalization, the potential and impact of smart innovations in clinical research.

Rightsizing CTMS: a new approach to operational data analysis and insights.

Modern clinical data concepts models, technology regulations risk based monitoring.

Personal

Lorem ipsum dolor sit amet.

Vestibulum vitae orci tortor.

Ea movet saperet rationibus.

Usu dictas imperdiet eu.

Enter your Google Map API from the Theme Settings panel.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse non posuere dolor, ut fermentum enim. Nullam quis molestie purus. Nam leo turpis, scelerisque in convallis ac, accumsan a lacus. Sed laoreet arcu in odio auctor commodo qisque et mi lacinia.

Photos
Meridian Clinical Trials - Presentation
5th Merdian Clinical Trails
Event Details
Sponsors